Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?

Mattia Novo,Grzegorz S. Nowakowski,Thomas M. Habermann,Thomas E. Witzig,Ivana N. Micallef,Patrick B. Johnston,David J. Inwards,Barbara Botto,Kay M. Ristow,Jason R. Young,Umberto Vitolo,Stephen M. Ansell

Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?

2019

Mattia Novo
Grzegorz S. Nowakowski
Thomas M. Habermann
Thomas E. Witzig
Ivana N. Micallef
Patrick B. Johnston
David J. Inwards
Barbara Botto
Kay M. Ristow
Jason R. Young
Umberto Vitolo
Stephen M. Ansell

AbstractResidual mediastinal FDG-uptake after frontline therapy for classical Hodgkin lymphoma (cHL) may constitute persistent disease or inflammatory changes. We analyzed practice patterns at two ...

Keywords:

Radiology
Diabetes mellitus
Immunology
Biopsy
Medicine
Lymphoma
PET-CT
Persistent Disease
fdg uptake
hodgkin lymphoma
ABVD
practice patterns

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations